Valuation: Allium Medical Solutions Ltd

Market Cap 31.89M 0 10.58M 9.22M 8.69M 7.91M 14.83M 1.01B 14.85M 104M 40.09M 516M 39.73M 38.85M 1.67B P/E 2024
-3.66x
P/E 2025 -2.14x
Enterprise Value 3.39M 0 1.12M 981K 924K 841K 1.58M 108M 1.58M 11.06M 4.26M 54.89M 4.22M 4.13M 177M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
59.89%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 2022-02-28
Director of Finance/CFO - 2021-11-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 70 -
Director/Board Member 56 2019-10-21
Director/Board Member 85 2016-07-13
Change 5-day change 1-year change 3-year change Capi.($)
-3.28%-4.11% - - 10.5M
-0.34%-2.72%-27.24%-3.61% 106B
+0.63%-1.38%-24.58%-0.43% 11.56B
-1.39%-5.59%+93.52%+114.66% 9.66B
+4.88%+6.11%-49.75%-66.69% 4.02B
+2.01%+0.94%-26.40%+22.21% 2.34B
-1.38%+1.88%-5.21%-60.40% 2.22B
+1.06%+6.15% - - 1.93B
+1.56%+3.35%-18.85%-27.25% 1.53B
Average +0.42%+1.24%-8.36%-3.07% 17.35B
Weighted average by Cap. -0.12%-2.21%-18.69%+2.41%

Financials

2024 2025
Net sales - -
Net income -8.75M -0 -2.9M -2.53M -2.38M -2.17M -4.07M -278M -4.07M -28.54M -11M -142M -10.9M -10.66M -457M -14.12M -0 -4.68M -4.08M -3.85M -3.5M -6.57M -449M -6.58M -46.06M -17.75M -229M -17.59M -17.2M -738M
Net Debt -42.56M -0 -14.11M -12.31M -11.59M -10.55M -19.79M -1.35B -19.81M -139M -53.5M -689M -53.01M -51.84M -2.22B -28.5M -0 -9.45M -8.24M -7.76M -7.07M -13.25M -905M -13.27M -92.95M -35.83M -461M -35.5M -34.72M -1.49B
Logo Allium Medical Solutions Ltd
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!